In this issue:
Classification and management of disorders of the J pouch
Spotlight on treatment response in Crohn's disease
Overview of biosimilars in IBD
Prognostic value of the modified Rutgeerts score
Second anti-TNF for patients with ulcerative colitis
Atherosclerosis as a risk factor for IBD
Comparative effectiveness of tacrolimus and infliximab in ulcerative colitis
Adalimumab biosimilar for severe Crohn’s disease and severe ulcerative colitis
The epidemiology of IBD in Oceania
3D modelling to guide interventional endoscopy
The reprocessing of reusable medical devices
Recent FDA approvals for ulcerative colitis
Please login below to download this issue (PDF)